MedPath

沈阳双鼎制药有限公司

Ownership
-
Established
2002-12-17
Employees
-
Market Cap
-
Website
www.shuangding.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

65

NMPA:65

Drug Approvals

Ornidazole Injection

Product Name
奥硝唑注射液
Approval Number
国药准字H20244809
Approval Date
Sep 3, 2024
NMPA

Ornidazole Injection

Product Name
奥硝唑注射液
Approval Number
国药准字H20244819
Approval Date
Sep 3, 2024
NMPA

Amiodarone Hydrochloride Injection

Product Name
盐酸胺碘酮注射液
Approval Number
国药准字H20244755
Approval Date
Aug 27, 2024
NMPA

Rifampicin for Injection

Product Name
注射用利福平
Approval Number
国药准字H20244486
Approval Date
Jul 30, 2024
NMPA

Dobutamine Hydrochloride Injection

Product Name
盐酸多巴酚丁胺注射液
Approval Number
国药准字H20244072
Approval Date
Jun 18, 2024
NMPA

Dobutamine Hydrochloride Injection

Product Name
盐酸多巴酚丁胺注射液
Approval Number
国药准字H20244071
Approval Date
Jun 18, 2024
NMPA

Isoniazid Injection

Product Name
异烟肼注射液
Approval Number
国药准字H20243830
Approval Date
May 28, 2024
NMPA

Eptifibatide Injection

Product Name
依替巴肽注射液
Approval Number
国药准字H20243134
Approval Date
Feb 6, 2024
NMPA

Tirofiban Hydrochloride and Sodium Chloride Injection

Product Name
盐酸替罗非班氯化钠注射液
Approval Number
国药准字H20234239
Approval Date
Dec 18, 2023
NMPA

Argatroban Injection

Product Name
阿加曲班注射液
Approval Number
国药准字H20234319
Approval Date
Oct 18, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy